Regen BioPharma Inc (RGBP)

[cvinvestor]

GM, I don't know what criteria has to be met for aplastic anemia, but as recall, the IND filed by RGBP had a qualified subset of aplastic anemia patients who had not responded to a certain treatment.

I'm just saying that the PR clearly wanted to communicate that this investigative study is outside their control and criteria, so it might not be a perfect match to what they have to follow under the IND for US trials, that's all.